•  
• Tweet
•  
•        Print
•  
•         Track Keywords
•  
• 

By Opalesque Geneva:

While the world wants to regulate AI, the regulators charged with overseeing various industries that use AI often find themselves with outdated tools that can limit effectiveness.

Some regulatory agencies are starting to adopt it. For example, regulatory bodies like the U.S. FDA, European Medicines Agency (EMA), and Japan's PMDA are using AI to accelerate drug approval processes and streamline data management.

Large consulting firm Deloitte in late 2023 argued that government regulators could change how they work if they used AI tools. "For example, generative AI can improve interactions with citizens and businesses, analyse and summarize large volumes of stakeholder input, automate administrative tasks like report generation, code software solutions, and even suggest tailored solutions."

The SEC itself is making a move in that direction.

The Securities and Exchange Commission reveal......................

To view our full article Click here